Novartis AG is 224.9x more valuable than MapLight Therapeutics, Inc. by market capitalization ($282.64 B vs $1.26 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | MPLT | NVS |
|---|---|---|
| Market cap | $1.26 B | $282.64 B |
| US-listed rank | #2467 | #47 |
| Net income (latest FY) | -$161.15M | - |
| SEC filings | 144 | 947 |
Novartis AG is 224.9x more valuable than MapLight Therapeutics, Inc. by market capitalization ($282.64 B vs $1.26 B).
Full pages: MapLight Therapeutics, Inc. and Novartis AG, or browse the full rankings.